Outcome Measures of Alexander Disease

Description

A thorough review of outcome measures that assess disease progression has not been established for any of the subcategories of Alexander disease. These results will be crucial to our understanding of disease presentation and progression. Providing this information about the pathophysiology will allow for effective development of clinical trials to test therapies and the future use of neuroprotective agents in children. IRB 16-012649

For More Information

Contact Us Online

Call (267) 426-6846


Related Conditions